Development of a CYP2C19 Genotype Guided Dosing Algorithm for Voriconazole

被引：0
|
作者：
Mangal, Naveen [1 ]
Hamadeh, Issam [2 ]
Samant, Tanay [1 ]
Schmidt, Stephan [1 ]
机构：
[1] Univ Florida, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA
[2] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-031
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis
    Ling, Jing
    Yang, Xuping
    Dong, Lulu
    Jiang, Yan
    Zou, Sulan
    Hu, Nan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
    Hui-Yan Shi
    Jin Yan
    Wen-Hui Zhu
    Guo-Ping Yang
    Zhi-Rong Tan
    Wei-Hua Wu
    Gan Zhou
    Xiao-Ping Chen
    Dong-Sheng Ouyang
    European Journal of Clinical Pharmacology, 2010, 66 : 1131 - 1136
  • [33] Correlation of CYP2C19 Phenotype With Voriconazole Plasma Concentration in Children
    Narita, Atsushi
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Doisaki, Sayoko
    Tanaka, Makito
    Hama, Asahito
    Shimada, Akira
    Takahashi, Yoshiyuki
    Yoshida, Nao
    Matsumoto, Kimikazu
    Kato, Koji
    Kudo, Kazuko
    Furukawa-Hibi, Yoko
    Yamada, Kiyofumi
    Kojima, Seiji
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (05) : E219 - E223
  • [34] Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
    Shi, Hui-Yan
    Yan, Jin
    Zhu, Wen-Hui
    Yang, Guo-Ping
    Tan, Zhi-Rong
    Wu, Wei-Hua
    Zhou, Gan
    Chen, Xiao-Ping
    Ouyang, Dong-Sheng
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) : 1131 - 1136
  • [35] Clinical importance of the CYP2C19*17 variant allele for voriconazole
    Dolton, Michael J.
    McLachlan, Andrew J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (01) : 137 - 138
  • [36] Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype
    Helsby, Nuala A.
    Lo, Wing-Yee
    Simpson, Ian J.
    Voss, David M.
    Logan, Kaye E.
    Searle, Martin
    Schollum, John B. W.
    de Zoysa, Janak R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 516 - 519
  • [37] The importance of CYP2C19 genotype in tacrolimus dose optimization when concomitant with voriconazole in heart transplant recipients
    Huang, Xiao
    Zhou, Ying
    Zhang, Jing
    Xiang, Hongping
    Mei, Hao
    Liu, Li
    Tong, Lu
    Zeng, Fang
    Huang, Yifei
    Zhou, Hong
    Zhang, Yu
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (10) : 4515 - 4525
  • [38] The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
    Wang, Guo
    Lei, He-Ping
    Li, Zhi
    Tan, Zhi-Rong
    Guo, Dong
    Fan, Lan
    Chen, Yao
    Hu, Dong-Li
    Wang, Dan
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (03) : 281 - 285
  • [39] The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
    Guo Wang
    He-Ping Lei
    Zhi Li
    Zhi-Rong Tan
    Dong Guo
    Lan Fan
    Yao Chen
    Dong-Li Hu
    Dan Wang
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2009, 65 : 281 - 285
  • [40] Voriconazole dose-related hepatotoxicity in a patient with an ultra-rapid CYP2C19 metabolizer genotype
    Pena-Lorenzo, D.
    Rebollo, N.
    Garcia-Casanueva, J. C.
    Martin-Gil, M.
    Otero, M. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1538 - 1538
12345